James Steven Reid

Title: Innovations by James Steven Reid

Introduction

James Steven Reid is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of neuroscience through his innovative methods for treating neurological deficits. With a total of 2 patents, Reid's work focuses on advancing medical treatments that can improve the quality of life for patients suffering from neurological conditions.

Latest Patents

Reid's latest patents include groundbreaking methods for treating neurological deficits. The first patent features methods and compositions for treating a patient with a neurological deficit by utilizing neural progenitor cells of the central nervous system (CNS). This method involves contacting these cells with a polypeptide that binds the epidermal growth factor (EGF) receptor, directing the progeny of the proliferating progenitor cells to migrate to specific regions of the CNS. This innovative approach aims to reduce neurological deficits effectively. The second patent also addresses neurological deficits through intrastriatal administration of transforming growth factor alpha (TGF-α), employing similar techniques to enhance the treatment process.

Career Highlights

James Steven Reid is associated with Neurorepair, Inc., where he continues to develop and refine his innovative methods. His work has garnered attention in the medical community for its potential to transform treatment protocols for neurological disorders.

Collaborations

Reid collaborates with James H. Fallon, further enhancing the research and development efforts at Neurorepair, Inc. Their combined expertise contributes to the advancement of innovative solutions in the field of neuroscience.

Conclusion

James Steven Reid's contributions to the field of neuroscience through his patents and collaborative efforts highlight his commitment to improving patient outcomes. His innovative methods for treating neurological deficits represent a significant advancement in medical science.